RU2004112422A - Роувастатин в преддеменционных состояниях - Google Patents
Роувастатин в преддеменционных состояниях Download PDFInfo
- Publication number
- RU2004112422A RU2004112422A RU2004112422/14A RU2004112422A RU2004112422A RU 2004112422 A RU2004112422 A RU 2004112422A RU 2004112422/14 A RU2004112422/14 A RU 2004112422/14A RU 2004112422 A RU2004112422 A RU 2004112422A RU 2004112422 A RU2004112422 A RU 2004112422A
- Authority
- RU
- Russia
- Prior art keywords
- rouvastatin
- prededentional
- conditions
- patient
- rosuvastatin
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 claims 3
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 2
- 229960000672 rosuvastatin Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| SE0103509-6 | 2001-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2004112422A true RU2004112422A (ru) | 2005-04-10 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004112422/14A RU2004112422A (ru) | 2001-10-19 | 2002-10-18 | Роувастатин в преддеменционных состояниях |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (https=) |
| EP (1) | EP1446123A1 (https=) |
| JP (1) | JP2005505605A (https=) |
| KR (1) | KR20040058201A (https=) |
| CN (1) | CN1604780A (https=) |
| AR (1) | AR036891A1 (https=) |
| BR (1) | BR0213434A (https=) |
| CA (1) | CA2463597A1 (https=) |
| CO (1) | CO5580773A2 (https=) |
| HU (1) | HUP0401798A3 (https=) |
| IL (1) | IL161380A0 (https=) |
| IS (1) | IS7218A (https=) |
| MX (1) | MXPA04003631A (https=) |
| NO (1) | NO20041840L (https=) |
| PL (1) | PL369573A1 (https=) |
| RU (1) | RU2004112422A (https=) |
| SE (1) | SE0103509D0 (https=) |
| WO (1) | WO2003032995A1 (https=) |
| ZA (1) | ZA200402844B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005023778A2 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| EP1601658A1 (en) | 2003-11-24 | 2005-12-07 | Teva Pharmaceutical Industries Limited | Crystalline ammonium salts of rosuvastatin |
| US7244844B2 (en) | 2003-12-02 | 2007-07-17 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
| WO2006017357A1 (en) | 2004-07-13 | 2006-02-16 | Teva Pharmaceutical Industries Ltd. | A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
| KR101020024B1 (ko) | 2005-02-22 | 2011-03-09 | 테바 파마슈티컬 인더스트리즈 리미티드 | 로수바스타틴 알킬에테르를 함유하지 않는 로수바스타틴 및이의 염 및 이의 제조 방법 |
| WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Withdrawn
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en not_active Ceased
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003032995A8 (en) | 2004-06-03 |
| IL161380A0 (en) | 2004-09-27 |
| AR036891A1 (es) | 2004-10-13 |
| CA2463597A1 (en) | 2003-04-24 |
| IS7218A (is) | 2004-04-13 |
| HUP0401798A2 (hu) | 2005-01-28 |
| KR20040058201A (ko) | 2004-07-03 |
| EP1446123A1 (en) | 2004-08-18 |
| BR0213434A (pt) | 2004-11-09 |
| CN1604780A (zh) | 2005-04-06 |
| PL369573A1 (en) | 2005-05-02 |
| HUP0401798A3 (en) | 2005-06-28 |
| WO2003032995A1 (en) | 2003-04-24 |
| SE0103509D0 (sv) | 2001-10-19 |
| MXPA04003631A (es) | 2004-07-30 |
| JP2005505605A (ja) | 2005-02-24 |
| US20060229321A1 (en) | 2006-10-12 |
| NO20041840L (no) | 2004-05-05 |
| ZA200402844B (en) | 2005-01-24 |
| CO5580773A2 (es) | 2005-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| EP1477119A4 (en) | METHOD FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS | |
| DE60128258D1 (de) | Indanylderivate zur Behandlung von Atemwegserkrankungen | |
| DE60030844D1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| NO20022014L (no) | En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| DK0503440T3 (da) | Sumatriptanholdige lægemidler | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| SE9901573D0 (sv) | New compounds | |
| JP2005511619A5 (https=) | ||
| EP1440689A3 (en) | Treatment of neurotic disorders | |
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| JP2005505605A5 (https=) | ||
| CA2432177A1 (en) | Drug for prevention and/or therapy of endometriosis | |
| BR0009080A (pt) | Método de tratamento da apnéia do sono | |
| SE9901572D0 (sv) | New compounds | |
| FI20011464A0 (fi) | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon | |
| LV11524A (lv) | Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana | |
| RU2005131943A (ru) | Лечебные и/или профилактические средства для хронических болезней кожи | |
| HUP0301873A2 (hu) | Gyógyszerkészítmény légzési nehézségek kezelésére | |
| TNSN99158A1 (ar) | طريقة لمنع الاصابة بالربو | |
| DE60206391D1 (de) | Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen | |
| DE60235965D1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
| WO2002047689A3 (en) | Use of cetirizine or efletirizine for preventing urticaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20060111 |